Free Trial

Bank of New York Mellon Corp Grows Holdings in Envista Holdings Corporation (NYSE:NVST)

Envista logo with Medical background

Bank of New York Mellon Corp grew its stake in shares of Envista Holdings Corporation (NYSE:NVST - Free Report) by 21.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,650,098 shares of the company's stock after buying an additional 287,564 shares during the period. Bank of New York Mellon Corp owned 0.97% of Envista worth $28,481,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of NVST. Franklin Resources Inc. increased its position in shares of Envista by 72.6% during the fourth quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company's stock valued at $132,223,000 after buying an additional 2,882,844 shares during the period. Brickwood Asset Management LLP bought a new stake in shares of Envista during the fourth quarter valued at about $40,037,000. Norges Bank bought a new stake in shares of Envista during the fourth quarter valued at about $38,052,000. Dimensional Fund Advisors LP increased its position in shares of Envista by 19.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 6,762,091 shares of the company's stock valued at $130,440,000 after buying an additional 1,089,923 shares during the period. Finally, Deerfield Management Company L.P. Series C increased its position in shares of Envista by 4,949.9% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 1,018,415 shares of the company's stock worth $19,645,000 after purchasing an additional 998,248 shares during the last quarter.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Piper Sandler decreased their price objective on shares of Envista from $18.00 to $17.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 30th. UBS Group reduced their price target on shares of Envista from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Monday, May 5th. Bank of America reduced their price target on shares of Envista from $26.00 to $23.00 and set a "buy" rating on the stock in a research report on Tuesday, April 29th. Morgan Stanley set a $16.00 target price on shares of Envista in a report on Tuesday, April 15th. Finally, Robert W. Baird upgraded shares of Envista from a "neutral" rating to an "outperform" rating and raised their target price for the stock from $21.00 to $23.00 in a report on Tuesday, May 27th. One research analyst has rated the stock with a sell rating, nine have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Envista has a consensus rating of "Hold" and an average target price of $20.23.

Read Our Latest Stock Analysis on NVST

Envista Stock Down 1.5%

Shares of NVST stock traded down $0.29 during mid-day trading on Friday, reaching $19.46. 1,980,932 shares of the company's stock traded hands, compared to its average volume of 2,465,036. Envista Holdings Corporation has a 12 month low of $14.22 and a 12 month high of $23.00. The company has a market cap of $3.30 billion, a P/E ratio of -2.98, a P/E/G ratio of 1.23 and a beta of 1.00. The company has a quick ratio of 1.82, a current ratio of 2.12 and a debt-to-equity ratio of 0.43. The company's 50-day moving average price is $18.91 and its 200-day moving average price is $18.53.

Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.20 by $0.04. Envista had a negative net margin of 44.90% and a positive return on equity of 4.07%. The company had revenue of $616.90 million for the quarter, compared to analysts' expectations of $608.17 million. During the same quarter in the previous year, the business posted $0.26 EPS. Envista's revenue was down 1.1% compared to the same quarter last year. On average, equities analysts expect that Envista Holdings Corporation will post 1 earnings per share for the current fiscal year.

Envista Company Profile

(Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

Featured Articles

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Should You Invest $1,000 in Envista Right Now?

Before you consider Envista, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.

While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines